Profiles of surface mosaics on chronic lymphocytic leukemias distinguish stable and progressive subtypes

Chronic lymphocytic leukemia (CLL) is a heterogeneous disease, some patients may survive for many years, while 20-30% of patients progress and may die within several years. Currently, there is not a single procedure that enables accurate prognosis and triaging of those patients who need immediate an...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmacy & pharmaceutical sciences Vol. 16; no. 2; pp. 231 - 237
Main Authors Huang, Pauline Y, Kohnke, Philippa, Belov, Larissa, Best, O Giles, Mulligan, Stephen Peter, Christopherson, Richard I
Format Journal Article
LanguageEnglish
Published Canada Frontiers Media S.A 01.01.2013
Subjects
Online AccessGet full text

Cover

Loading…